Literature DB >> 23000204

Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.

Jennifer C Felger1, Andrew H Miller.   

Abstract

Data suggest that cytokines released during the inflammatory response target subcortical structures including the basal ganglia as well as dopamine function to acutely induce behavioral changes that support fighting infection and wound healing. However, chronic inflammation and exposure to inflammatory cytokines appears to lead to persisting alterations in the basal ganglia and dopamine function reflected by anhedonia, fatigue, and psychomotor slowing. Moreover, reduced neural responses to hedonic reward, decreased dopamine metabolites in the cerebrospinal fluid and increased presynaptic dopamine uptake and decreased turnover have been described. This multiplicity of changes in the basal ganglia and dopamine function suggest fundamental effects of inflammatory cytokines on dopamine synthesis, packaging, release and/or reuptake, which may sabotage and circumvent the efficacy of current treatment approaches. Thus, examination of the mechanisms by which cytokines alter the basal ganglia and dopamine function will yield novel insights into the treatment of cytokine-induced behavioral changes and inflammatory malaise.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23000204      PMCID: PMC3484236          DOI: 10.1016/j.yfrne.2012.09.003

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  226 in total

1.  Oscillations in the basal ganglia.

Authors:  T Wichmann; M R DeLong
Journal:  Nature       Date:  1999-08-12       Impact factor: 49.962

2.  Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study.

Authors:  Yuriko Sugawara; Tatsuo Akechi; Yasuo Shima; Toru Okuyama; Nobuya Akizuki; Tomohito Nakano; Yosuke Uchitomi
Journal:  Palliat Med       Date:  2002-05       Impact factor: 4.762

Review 3.  Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.

Authors:  Hymie Anisman; Zul Merali; Shawn Hayley
Journal:  Prog Neurobiol       Date:  2008-02-13       Impact factor: 11.685

4.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

Review 5.  Astrocyte control of synaptic transmission and neurovascular coupling.

Authors:  Philip G Haydon; Giorgio Carmignoto
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

Review 6.  Treatment of cytokine-induced depression.

Authors:  Lucile Capuron; Peter Hauser; Dunja Hinze-Selch; Andrew H Miller; Pierre J Neveu
Journal:  Brain Behav Immun       Date:  2002-10       Impact factor: 7.217

7.  The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines.

Authors:  Hidetsugu Fujigaki; Kuniaki Saito; Suwako Fujigaki; Masao Takemura; Kaori Sudo; Hiroshi Ishiguro; Mitsuru Seishima
Journal:  J Biochem       Date:  2006-04       Impact factor: 3.387

8.  Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression.

Authors:  George I Papakostas; Timothy Petersen; David Mischoulon; Julie L Ryan; Andrew A Nierenberg; Teodoro Bottiglieri; Jerrold F Rosenbaum; Jonathan E Alpert; Maurizio Fava
Journal:  J Clin Psychiatry       Date:  2004-08       Impact factor: 4.384

9.  Systemic interferon-alpha regulates interferon-stimulated genes in the central nervous system.

Authors:  J Wang; I L Campbell; H Zhang
Journal:  Mol Psychiatry       Date:  2007-05-08       Impact factor: 15.992

10.  Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

Authors:  M J LaVoie; T G Hastings
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

View more
  133 in total

1.  Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptoms.

Authors:  Alan M Rathbun; Leslie R Harrold; George W Reed
Journal:  Clin Rheumatol       Date:  2014-08-27       Impact factor: 2.980

2.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

Review 3.  Interoception and Inflammation in Psychiatric Disorders.

Authors:  Jonathan Savitz; Neil A Harrison
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-01-09

4.  Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.

Authors:  Jennifer C Felger; Jiyoung Mun; Heather L Kimmel; Jonathon A Nye; Daniel F Drake; Carla R Hernandez; Amanda A Freeman; David B Rye; Mark M Goodman; Leonard L Howell; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2013-05-09       Impact factor: 7.853

5.  Biological Age, Not Chronological Age, Is Associated with Late-Life Depression.

Authors:  Patrick J Brown; Melanie M Wall; Chen Chen; Morgan E Levine; Kristine Yaffe; Steven P Roose; Bret R Rutherford
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-09-11       Impact factor: 6.053

6.  Exploratory Investigation of Early Biomarkers for Chronic Fatigue in Prostate Cancer Patients Following Radiation Therapy.

Authors:  Li Rebekah Feng; Brian S Wolff; Nada Lukkahatai; Alexandra Espina; Leorey N Saligan
Journal:  Cancer Nurs       Date:  2017 May/Jun       Impact factor: 2.592

7.  Pramipexole in Treatment Resistant-Depression, Possible Role of Inflammatory Cytokines.

Authors:  Rodrigo Escalona; Jan Fawcett
Journal:  Neuropsychopharmacology       Date:  2017-01       Impact factor: 7.853

8.  Anhedonia as a clinical correlate of inflammation in adolescents across psychiatric conditions.

Authors:  Rachel D Freed; Lushna M Mehra; Daniel Laor; Manishkumar Patel; Carmen M Alonso; Seunghee Kim-Schulze; Vilma Gabbay
Journal:  World J Biol Psychiatry       Date:  2018-08-16       Impact factor: 4.132

Review 9.  Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Authors:  J C Felger; F E Lotrich
Journal:  Neuroscience       Date:  2013-05-03       Impact factor: 3.590

10.  Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized Trial.

Authors:  Julie Lasselin; Michael T Treadway; Tamara E Lacourt; Anne Soop; Mats J Olsson; Bianka Karshikoff; Sofie Paues-Göranson; John Axelsson; Robert Dantzer; Mats Lekander
Journal:  Neuropsychopharmacology       Date:  2016-09-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.